Tradestie Institutional Equity Comparison Engine

ATHE vs ECOR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ECOR Overall Edge

ECOR Captures Institutional Edge (2โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to electroCore, Inc. Common Stock (ECOR) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, ATHE trades at N/M Forward P/E with -695.1% operating margin (-79.0% YoY revenue) versus ECOR at N/M Forward P/E and -33.1% operating margin (+11.5% YoY). In options structure, ATHE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ATHE N/M vs ECOR N/M Fwd P/E
Growth & Margin Winner ECOR
Op Margin -695.1% vs -33.1% ยท YoY -79.0% vs +11.5%
Momentum & Technical Winner ECOR
1Y -54.0% vs -4.0% ยท 52W Pos 3% vs 6%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ATHE NASDAQ
Alterity Therapeutics Limited American Depositary Shares
Pharmaceutical Preparations
$1.66
-2.65% 1D
Market Cap $32.5M
1M Return -30.75%
1Y Return -54.03%
Forward P/E N/M
Unified AI Score
39.2 / 100 SELL
Tech 25.0 Fund 42.0 Flow 50.0 Mom 55.0
ECOR NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap $47.7M
1M Return -34.01%
1Y Return -3.96%
Forward P/E N/M
Unified AI Score
56.8 / 100 HOLD
Tech 68.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ATHE -54.03% ECOR -3.96% Spread: +50.07 pp (ECOR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ATHE TTM Op. Margin: -695.1% ECOR TTM Op. Margin: -33.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ATHE vs ECOR. Trailing 12-month operating profitability (ATHE -695.1% vs ECOR -33.1%) and valuation multiples (ATHE N/M vs ECOR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ATHE (3) vs ECOR (5)
Institutional Metric ATHE ECOR Criterion Row Winner
Market Capitalization Scale $32.5M $47.7M Larger Scale ECOR
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -79.0% +11.5% Higher Growth ECOR
Operating Margin (TTM) Profitability -695.1% -33.1% Higher Margin ECOR
Net Profit Margin Profitability 0.0% -33.5% Higher Margin ATHE
Return on Equity (ROE) Capital Efficiency -55.0% -478.7% Higher ROE ATHE
52-Week Range Position Momentum 3% ($2โ€“$6) 6% ($4โ€“$13) Stronger Trend ECOR
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 102% Vol 1.52ฮฒ ยท 155% Vol Lower Realized Risk ATHE
Unified Institutional Score Composite Signal 39.2 / 100 (SELL) 56.8 / 100 (HOLD) Higher Composite ECOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ATHE vs ECOR Buy Guide
ATHE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ATHE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ECOR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ECOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ATHE nor ECOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.